First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.
Xiaohua WuJihong LiuRuifang AnRutie YinYu ZhangHuaijun ZhouAiqin HeLi WangJieqing ZhangZiling LiuWei DuanJian Qing ZhuGe LouGuilin ChenYing ChengFengxia XueSonja NickHaiyan WangDonghang LiPublished in: Journal of gynecologic oncology (2024)
ClinicalTrials.gov Identifier: NCT03635489.